Treatments for Advanced Prostate Cancer in 2022 | Evan Yu, MD | PCRI

Treatments for Advanced Prostate Cancer in 2022 | Evan Yu, MD | PCRI

Do You Radiate The Whole #Prostate While Having Metastatic Disease? | Evan Yu, MD & #MarkMoyadMDПодробнее

Do You Radiate The Whole #Prostate While Having Metastatic Disease? | Evan Yu, MD & #MarkMoyadMD

Active Surveillance in 2022 | Laurence Klotz, MD | PCRIПодробнее

Active Surveillance in 2022 | Laurence Klotz, MD | PCRI

PSMA Scans & Pluvicto (lutetium-177) in 2022 | Geoffrey Johnson, MD, PhD | PCRI Conference 2022Подробнее

PSMA Scans & Pluvicto (lutetium-177) in 2022 | Geoffrey Johnson, MD, PhD | PCRI Conference 2022

Incontinence & Impotence After Prostate Treatment | Jeffrey Brady, MD | PCRIПодробнее

Incontinence & Impotence After Prostate Treatment | Jeffrey Brady, MD | PCRI

What Is the Role Chemotherapy in Modern Day Prostate Cancer Treatment? | Evan Yu, MD Explains | PCRIПодробнее

What Is the Role Chemotherapy in Modern Day Prostate Cancer Treatment? | Evan Yu, MD Explains | PCRI

Immunotherapy's Role In Prostate Cancer | Evan Yu, MD & Mark Moyad, MD, MPH | PCRI 2020Подробнее

Immunotherapy's Role In Prostate Cancer | Evan Yu, MD & Mark Moyad, MD, MPH | PCRI 2020

Unexpected Responses to Prostate Cancer Treatments | 2019 PCRI ExcerptsПодробнее

Unexpected Responses to Prostate Cancer Treatments | 2019 PCRI Excerpts

PSMA & Lutetium-177 in 2022 | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer Part 4Подробнее

PSMA & Lutetium-177 in 2022 | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer Part 4

Day 2 | Advanced Treatments, LU-177, Extended Q+A | 2022 Prostate Cancer Patient ConferenceПодробнее

Day 2 | Advanced Treatments, LU-177, Extended Q+A | 2022 Prostate Cancer Patient Conference